ERCC1 Is a Prognostic Biomarker in Locally Advanced Head and Neck Cancer: Results From a Randomised, Phase II Trial

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2013.576
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phase I Trial of Concomitant Hyperfractionated Radiotherapy With Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

Cancer Journal
Cancer ResearchOncology
2006English

Cetuximab in Locally Advanced Head-And-Neck Cancer: Defining the Population

Current Oncology
Oncology
2010English

Twice-A-Day Fractionated Radiotherapy With Chemotherapy for Locally Advanced Head and Neck Cancer.

Japanese jornal of Head and Neck Cancer
1998English

Treatment of Locally Advanced Head and Neck Cancer: Historical and Critical Review

Cancer Control
MedicineOncologyHematology
2002English

Study of Hypofractionated Radiotherapy Regime for Locally Advanced Head and Neck Cancer

Journal of Medical Science And clinical Research
2019English

P1.08-009 Neutrophilia as Prognostic Biomarker in Locally Advanced Stage III Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

BACCHUS: A Randomised Non-Comparative Phase II Study of Neoadjuvant Chemotherapy (NACT) in Patients With Locally Advanced Rectal Cancer (LARC)

Heliyon
Multidisciplinary
2018English

A Phase II Randomised Trial of 5-Fluorouracil With or Without Interferon Alpha-2a in Advanced Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1996English

Reconstructive Surgery and Quality of Live in Patients With Locally-Advanced Head and Neck Cancer

Avicenna Bulletin
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy